 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that on September 8, 2023, the Compensation Committee of Acadias Board of Directors (the Committee) granted inducement awards consisting of...

Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Acadia Pharmaceuticals Inc (ACAD), where a total of 10,757 contracts have traded so far...

Noteworthy Wednesday Option Activity: ACAD, LULU, BYND

In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Acadia Pharmaceuticals Inc (ACAD) was identified as having a larger market cap than the smaller end of...

Acadia Pharmaceuticals Larger Than S&amp;P 500 Component DXC Technology

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will participate at the following upcoming investor conferences: Citi's 18th Annual BioPharma Conference Date: Wednesday, September...

Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD  Get Free Report) was the target of a significant increase in short interest during the month of August. As of August 15th, there was short interest...

Short Interest in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Increases By 10.3%

Skandinaviska Enskilda Banken AB publ lessened its stake in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD Free Report) by 4.7% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 60,514 shares of the ...

Skandinaviska Enskilda Banken AB publ Sells 2,956 Shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD  Get Free Report) CFO Mark C. Schneyer sold 10,000 shares of the firms stock in a transaction that occurred on Monday, August 21st. The stock was sold at an average price of $29.00, for a total transaction of $290,000.00. Following the sale, the...

Insider Selling: ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) CFO Sells $290,000.00 in Stock

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD  Get Free Report) has received a consensus rating of Hold from the thirteen research firms that are covering the stock, MarketBeat...

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Given Consensus Rating of "Hold" by Brokerages

Cantor Fitzgerald reissued their overweight rating on shares of ACADIA Pharmaceuticals (NASDAQ:ACAD Free Report) in a research report released on Tuesday , Benzinga reports. They currently have a $42.00 target price on the biopharmaceutical companys stock. ACAD has been the subject of several other ...

Cantor Fitzgerald Reiterates "Overweight" Rating for ACADIA Pharmaceuticals (NASDAQ:ACAD)

ACADIA Pharmaceuticals (NASDAQ:ACAD  Get Free Report)s stock had its overweight rating restated by equities researchers at Cantor Fitzgerald in a research report issued to clients and investors on Tuesday, Benzinga reports. They presently have a $42.00 target price on the...

Cantor Fitzgerald Reiterates Overweight Rating for ACADIA Pharmaceuticals (NASDAQ:ACAD)

ACADIA Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development and commercialization of medicines to address unmet medical needs in central nervous system, or CNS, disorders. Its products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. The company was founded by Mark R. Brann on July 16, 1993 and is headquartered in San Diego, CA.

Watchers	13,223
52-Wk Low	$13.73
52-Wk High	$33.99

Market Cap	$4.19B
Volume (M)	979.00
52-Wk High	$33.99
52-Wk Low	$13.73

ACAD Acadia Pharmaceuticals Inc

About

Feed

News

Sentiment

Earnings

Fundamentals